Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Mr. Forthright who wrote (642)	5/10/1998 11:29:00 PM
From: SOROS	Respond to of 1185

Perhaps you would care to do the Nortran vs Forbes Medi-Tech comparison? Thanks.

To: Mr. Forthright who wrote (642)	5/11/1998 12:32:00 AM
From: Wisee	Respond to of 1185

Mr. Forthright, It appears that you think that Nortran has been heavily promoted?? Please provide us with examples??, and do not include this SI thread as an example. Furthermore, I strongly disagree with your comment that "the promotion based on the whisper campaign brought the stock to where it is now". I have never bought a stock on a whisper campaign, and I don't think many have. Remember over 5 million shares traded in the last couple of weeks, and I find it difficult to believe that many of those shares were bought on the whisper campaign. Whisper campaigns (rumours) usually last a couple of days or weeks and then fizzle out. Looking at NRT's chart, it has had a nice steady increase since February. Many did their due diligence on Nortran, and realized that it was undervalued. When was the last time a VSE company announced that it did a financing for $10 million?? I suspect those that bought in, did their due diligence before committing that kind of money. Wisee